This country profile provides an overview of Mauritania’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Mauritania
- Mauritania is encouraged to maintain the high levels of coverage for bilharzia in school age children.
- For trachoma, it should conduct surveys in Hodh El Charghui (Nema, Timbedra, Basseknou, Amourj, and Oualata) in 2019 to establish the endemicity status and decide whether there is need for interventions or not. This would help complete the mapping of trachoma for the country, in preparation of a potential elimination dossier.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Mauritania does not require mass treatment for elephantiasis.
Treatment coverage was 0% in 2016 and 2017.
Mauritania does not require mass treatment for intestinal worms.
Treatment coverage increased from 0% in 2016 to 82% in 2017.
Mauritania does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mauritania.